Fertility News and Research

RSS

Georgetown's Institute for Reproductive Health receives $30 million from USAID to support Passages Project

The U.S. Agency for International Development has awarded $30 million to Georgetown University Medical Center's Institute for Reproductive Health to fund its Passages Project, which aims to improve healthy timing and spacing of pregnancies among youth and first-time parents in developing countries.

22 Jul 2015

MD Anderson researchers find high prevalence of hereditary CRC among people diagnosed before the age of 35

Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at The University of Texas MD Anderson Cancer Center have discovered a particularly high prevalence of hereditary cancers among those diagnosed with the disease before the age of 35. They suggest that these patients should undergo genetic counseling to determine if their families may be at an elevated risk.

21 Jul 2015

MES announces worldwide release of new automated sperm quality analyzer

Medical Electronic Systems today announced the worldwide release of the SQA-Vision, the company's new automated sperm quality analyzer. The SQA-Vision was developed based on 10 years of market feedback and is positioned to augment the company's line of SQA-V and QwikCheck semen analyzers with a top of the line solution.

17 Jul 2015

Cancer survivors' options for adoption may be limited by policies set by adoption agencies

A new study has found that cancer survivors' options for adoption may be limited by adoption agencies' policies. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also indicates that a training program for oncology healthcare providers can help them provide valuable information to patients who are making decisions about fertility and adoption.

13 Jul 2015

Researchers develop sperm RNA diagnostic test to help determine best infertility treatment for couples

A Wayne State University School of Medicine professor, in collaboration with researchers at CReAte Fertility Center, University of Toronto, Harvard University and Georgia Reagents University, has developed the first diagnostic test for sperm RNA based on next-generation sequencing. For couples with unexplained infertility, the test may help determine the best infertility treatment for couples having difficulty conceiving.

12 Jul 2015

Out-of-pocket expenses for oral contraceptive pills, IUD decrease since the ACA took effect: Study

Average out-of-pocket spending for oral contraceptive pills and the intrauterine device (IUD), the two most common forms of contraception for women, has decreased significantly since the Affordable Care Act (ACA) took effect.

8 Jul 2015

IRB Barcelona scientists provide molecular details about Seckel Syndrome

Today in Nature Communications, scientists at the Institute for Research in Biomedicine (IRB Barcelona) provide molecular details about Seckel Syndrome, a rare disease that causes microcephaly, or small brain, and growth delays.

8 Jul 2015

Aytu BioScience now trading under new symbol following its corporate name change

Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions, announced today that the company is now trading under the new symbol "AYTU," following its corporate name change, which became effective June 8, 2015.

7 Jul 2015

Research Instruments receives European patent for RI Witness system

Research Instruments Ltd, a company that develops cutting edge technology and biomedical equipment for use in the Assisted Reproduction (AR) sector, today announced the company has been awarded a European patent for their RI Witness system. It's the first to issue from a portfolio of patents filed for RI Witness.

6 Jul 2015

New handbook explores issues associated with medical tourism

Patients who travel abroad for medical treatment risk returning with complications or infections that require costly treatment on the NHS and is one of the issues highlighted in a new handbook exploring medical tourism.

30 Jun 2015

Groundbreaking UVA research may lead to creation of male contraceptive

Groundbreaking new reproductive research from the School of Medicine has identified key molecular events that could be playing a critical role as sperm and egg fuse to create new life. The findings might one day lead to the creation of a male contraceptive.

24 Jun 2015

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Eli Lilly and Company announced that The Lancet Oncology has published results of the Phase III REACH trial that evaluated CYRAMZA (ramucirumab) as a second-line treatment for people with hepatocellular carcinoma (HCC), also known as liver cancer. While the REACH trial's primary endpoint of overall survival favored the CYRAMZA arm, it was not statistically significant.

19 Jun 2015

Rare form of autoimmune syndrome may be tied to mutations in AIRE gene

A hereditary autoimmune disease that was thought to be exceedingly rare may have a less severe form that affects one in 1,000 people or even more, according to new research conducted at the Weizmann Institute of Science, in Israel, and the University of Bergen, in Norway.

18 Jun 2015

Beckman Coulter brings new thinking to new lab challenges at EuroMedLab 2015

Beckman Coulter Diagnostics supports IFCC-EFLM EuroMedLab 2015 with a showcase of solutions to improve workflow for the diagnostics laboratory. Held from 22-24 June 2015 at the Paris Palais des Congrès France, the company demonstrates its dedication to moving the clinical diagnostic lab forward with its total laboratory solution—from automation, chemistry, immunoassay and haematology to microbiology and its new molecular diagnostics system.

From Beckman Coulter Diagnostics 18 Jun 2015

Women who underwent uterine transplantation adjust to sudden restoration of fertility

In October last year the Gothenburg, Sweden, group of Mats Bra?nnstro?m announced the world's first live birth following the transplantation of a donated uterus.

17 Jun 2015

Merck KGaA, Darmstadt, Germany announces CE Mark certification for two innovative fertility technologies

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced that the two innovative fertility technologies Gavi and Geri have cleared a major milestone, achieving CE Mark certification.

15 Jun 2015

Higher obstetric risk identified in ART pregnancies not linked to poorer academic performance in children

The academic performance of children conceived by assisted reproduction techniques (ART) is no better or worse than that of spontaneously conceived children when assessed at the ninth grade of their school education.

15 Jun 2015

NSAIDs significantly inhibit ovulation in women with mild musculoskeletal pain

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) show that diclofenac, naproxen and etoricoxib significantly inhibit ovulation in women with mild musculoskeletal pain. Of the women receiving NSAIDs, only 6.3 percent (diclofenac), 25 percent (naproxen) and 27.3 percent (etoricoxib) ovulated, compared with 100 percent of the control group.

12 Jun 2015

WHO's updated essential medicines list includes progesterone contraceptive vaginal ring

The World Health Organization released its 2015 updated essential medicines list and for the first time included the progesterone contraceptive vaginal ring (CVR), a contraceptive safe and effective for lactating women in the postpartum period.

10 Jun 2015

Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced the formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory.

From Illumina, Inc. 8 Jun 2015